Recently, the Finance Department of the National Health and Family Planning Commission organized the 2016 Expert Meeting on Import Equipment to consolidate and improve the “centralized argumentation and unified approval†of the approval methods for imported equipment, promote the implementation of support for the development of domestic equipment applications, standardize the examination and approval of imported equipment, and improve work. effectiveness.
At the meeting, Wang Mingxia, Director of the Price Assets Division of the Finance Department of the National Health and Family Planning Commission, reported the results and results of the “concentration argumentation and unified approval†in 2015.
In 2015, it successively demonstrated 2,925 sets/sets of imported products declared by 75 budgetary units, and agreed to approve 1,952 sets/sets of imported products, accounting for 67% of the total number of applications.
In order to institutionalize and standardize this practice, in January 2016, the National Health and Family Planning Commission issued the “Measures for the Administration of Imported Equipment for Government Procurement of the Budget Unit of the National Health and Family Planning Commission (Trial)â€.
According to incomplete statistics, from the procurement situation of the equipment of the budget unit of the National Health and Family Planning Commission, the procurement of imported products by various units accounted for a relatively large proportion, and the purchase share of domestically produced equipment accounted for a relatively small proportion, which affected the development of domestic medical equipment to some extent.
At the same time, after the purchase of imported products by various units, especially the large-scale medical equipment of foreign brands, after the sale in China, a high monopoly of maintenance services and accessories consumables market based on technology monopoly has been formed, resulting in increased operating costs of various units. Passively accepting the requirements of the supplier, the bargaining power is weak.
From the composition of the top ten diseases in China, chronic diseases such as malignant tumors, cardiovascular and cerebrovascular diseases, and diabetes have become important causes of death, which have caused important impacts on people's lives.
From the perspective of disease diagnosis and treatment, the use of advanced medical equipment, including CT, magnetic resonance, PET-CT, TOMO and other large equipment, has become an important tool for the diagnosis and treatment of major diseases.
The current reality is that China's medical equipment low-end market is dominated by domestic products, and the high-end market is basically occupied by foreign companies, and it is infiltrating the domestic low-end market.
High-end equipment investment is large, increasing the procurement cost. The after-sales and maintenance of imported equipment are carried out by the original company's specialized personnel. Once the maintenance delays due to some reasons, the supply of consumables is interrupted, the use of equipment will be embarrassed.
In addition, the core technology of high-end medical equipment is in the hands of foreign companies, and information security such as medical diagnosis, treatment data and patient medical files are also facing great risks.
Facing the current situation of the medical equipment market, supporting the development and application of domestic medical equipment is related to the strategic development of China's country.
“Expert review should take into account factors such as clinical use needs and application areas, and combine the development of national industries, and consider products with independent innovation and advanced technology as important conditions for encouraging and supporting procurement.†Wang Mingxia said, increase domestic high-end medical care. The procurement participation of equipment, continuously expand the share of domestic equipment procurement, and do a good job in government procurement to support small and micro enterprises, energy-saving and environmentally friendly products. Therefore, where domestic products can replace imported products, domestic products should be preferred.
It is understood that 25 experts in the industry were invited to the seminar, including one legal expert, and more than half of them were from non-budget units. The purpose was to ensure fair, just and objective evaluation of the argumentation work, and at the same time, group double blindness was adopted. Review system.
GMP Certificated Immune Globulin Injection Supplier in China
Hepatitis B Immunoglobulin,Hep B Immunoglobulin,Hepatitis B Immunoglobulin Vaccine,Hepatitis Immune Globulin
FOSHAN PHARMA CO., LTD. , https://www.full-pharma.com